InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Allen Robert D. III, Chief Scientific Officer. Officer active across 1 company, notably Invivyd, Inc.. Cumulatively, 7 reports have been published. Breakdown: 0 buy · 4 sells. Total volume traded: €49k. History available since 19 August 2025. The latest transaction was filed on 17 August 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Allen Robert D. III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报7 总计
102,000 股Common StockSEC:0001193125-26-355911:0
20,679 股@ US$0.722Common StockSEC:0001193125-26-355911:1
17,043 股@ US$0.8429Common StockSEC:0001193125-26-355911:2
99,000 股Common StockSEC:0001193125-26-057828:0
99,000 股Common StockSEC:0000950170-25-110339:0
18,512 股@ US$0.650243.6% 占其流量Common StockSEC:0000950170-25-110339:1
27,420 股@ US$0.566656.4% 占其流量Common StockSEC:0000950170-25-110339:2
7 条申报中的 7 条
About Allen Robert D. III
Robert D. Allen III is the Chief Scientific Officer at Invivyd, Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and scientific advancement. With a strong background in science, he plays a crucial role in product strategy and the development of new technologies. His expertise contributes to the company's mission of improving health and well-being.
